BIO · Bio-Rad Laboratories, Inc.
$327.25
-3.75 (-1.13%)
At close · Jul 29
Market Cap
$8.86B
Shares
26.76M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-04-30 | — | |
| 10-Q | 2026-04-30 | 2026-03-31 | |
| 8-K | 2026-04-24 | 2026-04-21 | |
| Investor Event Transcript | 2026-03-31 | — | |
| DEF 14A | 2026-03-25 | 2026-04-21 | |
| 8-K | 2026-02-19 | — | |
| 10-K | 2026-02-13 | 2025-12-31 | |
| 8-K | 2026-02-12 | — | |
| 8-K | 2025-10-29 | — | |
| 10-Q | 2025-10-29 | 2025-09-30 | |
| 8-K | 2025-09-30 | 2025-09-29 | |
| 8-K | 2025-08-26 | — | |
| 10-Q | 2025-07-31 | 2025-06-30 | |
| 8-K | 2025-07-31 | — | |
| 8-K | 2025-07-28 | — | |
| 8-K | 2025-06-30 | — | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| 8-K | 2025-05-01 | — | |
| 8-K | 2025-04-25 | 2025-04-22 | |
| DEF 14A | 2025-03-26 | 2025-04-22 | |
| 8-K | 2025-02-21 | — | |
| 10-K | 2025-02-14 | 2024-12-31 | |
| 8-K | 2025-02-13 | 2025-02-07 | |
| 10-Q | 2024-10-31 | 2024-09-30 | |
| 8-K | 2024-10-30 | — | |
| 8-K | 2024-09-09 | 2024-09-06 | |
| 8-K | 2024-08-20 | 2024-08-15 | |
| 10-Q | 2024-08-02 | 2024-06-30 | |
| 8-K | 2024-08-01 | 2024-07-29 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| 8-K | 2024-04-26 | 2024-04-22 | |
| 8-K | 2024-04-10 | — | |
| DEF 14A | 2024-03-27 | 2024-04-23 | |
| 8-K | 2024-03-20 | — | |
| 8-K | 2024-02-21 | — | |
| 10-K | 2024-02-16 | 2023-12-31 | |
| 8-K | 2024-02-15 | — | |
| 8-K | 2024-02-14 | 2024-02-09 | |
| 8-K | 2023-12-07 | 2023-12-04 | |
| 10-Q | 2023-10-27 | 2023-09-30 | |
| 8-K | 2023-10-26 | — | |
| 8-K | 2023-10-17 | 2023-10-12 | |
| 8-K | 2023-08-25 | 2023-08-21 | |
| 10-Q | 2023-08-04 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-07-20 | — | |
| 8-K | 2023-06-05 | — | |
| 10-Q | 2023-05-05 | 2023-03-31 |
Showing 1–50 of 99 filings
Key facts
CIK
12208
CUSIP
090572207
13F (30d)
132 filings
105 filers
Visit website
Investor relations